3 assets in Basal-Like Breast Carcinoma

Therapeutic assets addressing Basal-Like Breast Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Abemaciclib Basal-Like Breast Carcinoma	Danish Breast Cancer Cooperative Group	P3	B (60)
Ribociclib Basal-Like Breast Carcinoma	Danish Breast Cancer Cooperative Group	P3	B (60)
Trastuzumab Deruxtecan Basal-Like Breast Carcinoma	Danish Breast Cancer Cooperative Group	P3	B (60)